Mycobacterial infections in a large Virginia hospital, 2001-2009
<p>Abstract</p> <p>Background</p> <p>In areas where both tuberculosis (TB) and nontuberculous mycobacteria (NTM) are prevalent, descriptive studies of the clinical features of individual mycobacteria are needed to inform clinical triage.</p> <p>Methods</p...
Main Authors: | Scully Kenneth W, Heysell Scott K, Satyanarayana Gowri, Houpt Eric R |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-05-01
|
Series: | BMC Infectious Diseases |
Online Access: | http://www.biomedcentral.com/1471-2334/11/113 |
Similar Items
-
Therapeutic Drug Monitoring for Slow Response to Tuberculosis Treatment in a State Control Program, Virginia, USA
by: Scott K. Heysell, et al.
Published: (2010-10-01) -
Early Therapeutic Drug Monitoring for Isoniazid and Rifampin among Diabetics with Newly Diagnosed Tuberculosis in Virginia, USA
by: Scott K. Heysell, et al.
Published: (2013-01-01) -
National hospital costs for pulmonary mycobacterial diseases in the US from 2001 to 2012
by: Mehdi Mirsaeidi, et al.
Published: (2015-01-01) -
Nontuberculous mycobacterial infection in a tertiary care center in Mexico, 2001–2017
by: Bruno Ali Lopez-Luis, et al.
Published: (2020-05-01) -
Mycobacterial Testing Trends, United States, 2009–2015
by: Samantha G. Dean, et al.
Published: (2020-09-01)